WDR45 Antibody Blocking peptide
WDR45 Antibody Blocking peptide
Product Specifications
Product Name Alternative
WD repeat domain phosphoinositide-interacting protein 4, WIPI-4, WD repeat-containing protein 45, WDR45, WDRX1, WDRXI4, WIPI4
UniProt
Q9Y484
Field of Research
Cell Biology
Form
Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Notes
For research use only.
Applications Notes
Synthetic peptide
AA Sequence
The synthetic peptide sequence was selected from the N-term region of WDR45. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
OR1091295-01 250 mg
(4- ((4-methoxybenzyl) oxy) -2-methylphenyl) (methyl) sulfane
Sign In for Pricing
View Details OR1091295-02 500 mg
(4- ((4-methoxybenzyl) oxy) -2-methylphenyl) (methyl) sulfane
Sign In for Pricing
View Details OR1091295-03 1 g
(4- ((4-methoxybenzyl) oxy) -2-methylphenyl) (methyl) sulfane
Sign In for Pricing
View Details